Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 3Trigger Finger Disorder 1Stomach Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Nose Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Kidney Neoplasms 1Ganglion Cysts 1Esthesioneuroblastoma, Olfactory 1Dupuytren Contracture 1De Quervain Disease 1Colorectal Neoplasms 1Cognitive Dysfunction 1Carpal Tunnel Syndrome 1Cachexia 1Biliary Tract Neoplasms 1

Interventions

Tomography, X-Ray Computed 1Radiotherapy 1Radionuclide Imaging 1Positron-Emission Tomography 1Ibuprofen 1Hydroxyurea 1Fluorouracil 1Electrocardiography 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nose Neoplasms × Ibuprofen × Clear all
NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡